BIOSPECIFICS TECHNOLOGIES CORP: 10-K filed 2012-03-13
What BIOSPECIFICS TECHNOLOGIES CORP reported in its annual report filed 2012-03-13 (fiscal FY 2011): 29 published measures, 82 facts as tagged in accession 0001140361-12-015150.
This filing
- Form
- 10-K (annual report)
- Filed
- 2012-03-13
- Fiscal period
- fiscal FY 2011
- Accession
- 0001140361-12-015150 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIOSPECIFICS TECHNOLOGIES CORP filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 16,265,073 | USD | |
| At 2010-12-31 | 11,518,701 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 14,872,314 | USD | |
| At 2010-12-31 | 6,700,723 | USD | |
| At 2009-12-31 | 6,092,107 | USD | |
| At 2008-12-31 | 6,178,539 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 3,196,831 | USD | |
| At 2010-12-31 | 2,470,852 | USD | |
| At 2009-12-31 | 3,950,389 | USD | |
| At 2008-12-31 | 3,494,150 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 6,601,626 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -1,508,540 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -1,956,543 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -687,589 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -882,482 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 3,724,751 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 1,052,598 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 215,374 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 380,029 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 360,970 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -812,429 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -3,648,541 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | -3,291,904 | USD | |
| At 2010-12-31 | -9,893,530 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 6,340,648 | shares | 365 |
| 2010-01-01 to 2010-12-31 | 6,261,214 | shares | 365 |
| 2009-01-01 to 2009-12-31 | 6,065,939 | shares | 365 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 7,107,134 | shares | 365 |
| 2010-01-01 to 2010-12-31 | 6,261,214 | shares | 365 |
| 2009-01-01 to 2009-12-31 | 6,065,939 | shares | 365 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 1.04 | USD/shares | 365 |
| 2010-01-01 to 2010-12-31 | -0.24 | USD/shares | 365 |
| 2009-01-01 to 2009-12-31 | -0.32 | USD/shares | 365 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 0.93 | USD/shares | 365 |
| 2010-01-01 to 2010-12-31 | -0.24 | USD/shares | 365 |
| 2009-01-01 to 2009-12-31 | -0.32 | USD/shares | 365 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -1,338,256 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 1,351 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -161,574 | USD | 365 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 517,367 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 1,901,781 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 1,490,083 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 5,191,767 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -2,033,032 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -2,164,908 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 13,086,503 | USD | |
| At 2010-12-31 | 10,095,258 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 0 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 0 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 39 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 1,116,239 | USD | |
| At 2010-12-31 | 4,104,359 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 3,236,917 | USD | |
| At 2010-12-31 | 1,986,125 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 739,551 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 458,001 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 0 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 972,078 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 1,223,931 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 488,646 | USD | 365 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 20,049,196 | USD | |
| At 2010-12-31 | 17,739,765 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 98,233 | USD | |
| At 2010-12-31 | 91,925 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 5,263,370 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -1,507,189 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -2,118,117 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 5,231,881 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 6,470,449 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 4,832,019 | USD | 365 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 50,685 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 18,949 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 35,669 | USD | 365 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 50,685 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 36,041 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 33,983 | USD | 365 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 71,603 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 525,843 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 46,791 | USD | 365 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 1,250,792 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 459,291 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -5,616,601 | USD | 365 |
Inspect the source
- Entity
- BIOSPECIFICS TECHNOLOGIES CORP / CIK 0000875622
- Captured
- SEC response SHA-256
b1d443fa8a2de5e07d7cbcf40e33944d546011c718a394f04bbb863281862def
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000875622.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))